228 related articles for article (PubMed ID: 30215805)
21. A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease.
Naismith GD; Smith LA; Barry SJ; Munro JI; Laird S; Rankin K; Morris AJ; Winter JW; Gaya DR
J Crohns Colitis; 2014 Sep; 8(9):1022-9. PubMed ID: 24566170
[TBL] [Abstract][Full Text] [Related]
22. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
[TBL] [Abstract][Full Text] [Related]
23. Parameters of body composition and creeping fat are associated with activity of Crohn's disease.
Barajas Ordonez F; Melekh B; Rodríguez-Feria P; Damm R; Thormann M; March C; Omari J; Pech M; Surov A
Magn Reson Imaging; 2023 May; 98():1-6. PubMed ID: 36634829
[TBL] [Abstract][Full Text] [Related]
24. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors.
Abraham TM; Pedley A; Massaro JM; Hoffmann U; Fox CS
Circulation; 2015 Oct; 132(17):1639-47. PubMed ID: 26294660
[TBL] [Abstract][Full Text] [Related]
25. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
Beltrán B; Iborra M; Sáez-González E; Marqués-Miñana MR; Moret I; Cerrillo E; Tortosa L; Bastida G; Hinojosa J; Poveda-Andrés JL; Nos P
Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385
[TBL] [Abstract][Full Text] [Related]
26. Association between disease duration and usefulness of fecal calprotectin measurement in patients with Crohn's disease.
Eder P; Stawczyk-Eder K; Łykowska-Szuber L; Krela-Kaźmierczak I; Klimczak K; Szymczak A; Szachta P; Linke K
Pol Arch Med Wewn; 2014; 124(1-2):51-7. PubMed ID: 24424551
[TBL] [Abstract][Full Text] [Related]
27. Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
Cerrillo E; Beltrán B; Pous S; Echarri A; Gallego JC; Iborra M; Pamies J; Nos P
Inflamm Bowel Dis; 2015 Jul; 21(7):1572-9. PubMed ID: 26052967
[TBL] [Abstract][Full Text] [Related]
28. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
Zulian A; Cancello R; Micheletto G; Gentilini D; Gilardini L; Danelli P; Invitti C
Gut; 2012 Jan; 61(1):86-94. PubMed ID: 21930728
[TBL] [Abstract][Full Text] [Related]
29. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
30. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
33. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study.
Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY
Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068
[TBL] [Abstract][Full Text] [Related]
34. Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up.
Jones GR; Fascì-Spurio F; Kennedy NA; Plevris N; Jenkinson P; Lyons M; Wong L; MacLean P; Glancy S; Lees CW
J Crohns Colitis; 2019 Mar; 13(4):442-450. PubMed ID: 30452618
[TBL] [Abstract][Full Text] [Related]
35. Abdominal Adiposity Distribution Quantified by Ultrasound Imaging and Incident Hypertension in a General Population.
Seven E; Thuesen BH; Linneberg A; Jeppesen JL
Hypertension; 2016 Nov; 68(5):1115-1122. PubMed ID: 27620395
[TBL] [Abstract][Full Text] [Related]
36. Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman SN; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200405
[TBL] [Abstract][Full Text] [Related]
37. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
[TBL] [Abstract][Full Text] [Related]
38. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.
Hukkinen M; Pakarinen MP; Merras-Salmio L; Koivusalo A; Rintala R; Kolho KL
J Pediatr Surg; 2016 Sep; 51(9):1467-72. PubMed ID: 26891835
[TBL] [Abstract][Full Text] [Related]
39. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.
Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K
World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509
[TBL] [Abstract][Full Text] [Related]
40. Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.
Bourgonje AR; von Martels JZH; de Vos P; Faber KN; Dijkstra G
PLoS One; 2018; 13(2):e0193202. PubMed ID: 29466406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
